Form 4: Addus HomeCare Director Darin Gordon Receives Restricted Stock Grant

Darin J. Gordon, a Director at Addus HomeCare Corp (ADUS), was granted 1,172 restricted shares of common stock as part of non-employee director compensation, vesting in June 2026.

Summary

• Darin J. Gordon, a Director of Addus HomeCare Corp (ADUS), acquired 1,172 shares of common stock.
• The transaction occurred on June 18, 2025.
• These shares were granted as restricted stock to non-employee directors.
• The granted shares will vest in full on June 18, 2026.
• Following this transaction, Darin J. Gordon beneficially owns 12,795 shares of common stock directly.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it represents a routine, expected compensation event that aligns director interests with shareholders, without indicating any negative operational or financial news.

Positives

• The grant of restricted shares aligns the interests of Director Darin J. Gordon with those of shareholders, as the value of his compensation is tied to the company's stock performance.
• This is a routine compensation practice for non-employee directors, indicating standard corporate governance procedures are in place.

Negatives

• The issuance of new shares, even restricted ones, can result in minor dilution for existing shareholders, though the amount in this filing is negligible.

Future Outlook

The restricted shares granted to Director Darin J. Gordon are scheduled to vest in full on June 18, 2026, indicating a future milestone for this compensation.

Industry Context

This transaction reflects a common practice in the healthcare services industry, where non-employee directors receive equity compensation to align their long-term interests with the company's performance and shareholder value. Addus HomeCare operates in the home care sector, which is experiencing growth due to an aging population and a preference for in-home services.

Comparison to Industry Standards

• The grant of restricted stock to non-employee directors is a standard compensation practice across various industries, including healthcare services. Companies like LHC Group (now part of UnitedHealth Group), Amedisys, Inc., and Encompass Health Corporation also utilize equity-based compensation to attract and retain qualified independent directors.
• The specific number of shares granted (1,172) would typically be benchmarked against the total compensation package for directors at peer companies of similar market capitalization and revenue within the home healthcare sector to assess its competitiveness and appropriateness.

Corporate Governance

Related Party Transactions

• The grant of restricted shares to Darin J. Gordon, a Director of Addus HomeCare Corp, constitutes a related party transaction as it involves compensation from the company to a member of its board.

Stakeholder Impact

• Shareholders: Minor potential for dilution due to the issuance of new shares, but also improved alignment of director incentives with shareholder interests.
• Employees: No direct impact mentioned in this filing.
• Customers: No direct impact mentioned in this filing.
• Suppliers: No direct impact mentioned in this filing.
• Creditors: No direct impact mentioned in this filing.

Next Steps

• The restricted shares granted to Darin J. Gordon are expected to vest in full on June 18, 2026.

Key Dates

Keywords

Addus HomeCare, ADUS, Darin J. Gordon, Restricted Stock, Director Compensation, SEC Form 4, Insider Transaction, Equity Grant, Home Healthcare